The first medical device for non-invasive detection and monitoring of infant meningitis

NEOSONICS is a non-invasive ultrasound device that detects infant meningitis by analyzing cerebrospinal fluid white blood cell levels, aiming to reduce reliance on risky lumbar punctures.

Subsidie
€ 2.500.000
2022

Projectdetails

Introduction

Meningitis is a life-threatening disease that can kill in a matter of hours or cause life-long disabilities if not detected promptly. Infants (<12 months) are the most vulnerable population with a compromised immunologic system.

Current Detection Methods

Although the incidence is relatively low in industrialized countries, neonatologists only count on lumbar punctures as the gold standard method to detect the disease. This method is invasive, risky, and cost-inefficient.

NEOSONICS Device

NEOSONICS is a patented first-in-class medical device based on high-frequency ultrasound to non-invasively detect and monitor infant meningitis.

Device Functionality

  • The hand-held device is placed on the open fontanelle of a baby.
  • Due to proprietary coupling materials and in-house developed machine learning algorithms, it detects the level of white blood cells in the cerebrospinal fluid at a sensitivity of 100%.

Impact on Clinical Practice

With NEOSONICS, lumbar punctures will be limited to only a few patients with infection (and no lumbar puncture contraindication) that will be non-invasively assessed with our innovation.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.500.000
Totale projectbegroting€ 4.125.058

Tijdlijn

Startdatum1-12-2022
Einddatum31-8-2025
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • NEOS NEW BORN SOLUTIONS SLpenvoerder

Land(en)

Spain

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

Sonio: Deep-Learning for Detection and Diagnostic of Prenatal Malformations

Sonio is an AI-driven platform that enhances fetal ultrasound by guiding OBGYNs in detecting congenital malformations, aiming to improve prenatal diagnosis accuracy and outcomes.

€ 2.500.000
EIC Accelerator

Bringing newborn care home: An integral mHealth solution for neonatal jaundice management.

Picterus is creating a digital platform for at-home neonatal jaundice screening, empowering families to monitor conditions and streamline healthcare referrals, improving outcomes and resource efficiency.

€ 2.499.999
EIC Accelerator

Point of care diagnostic solution for definitive differentiation of true and false threatened preterm labour cases

INNITIUS aims to optimize TPTL diagnosis with Fine Birth, a non-invasive AI-driven device that assesses cervical tissue consistency, seeking €2.5M for further development and regulatory approval.

€ 2.342.835
EIC Accelerator

World’s first diagnostic test that can detect all bacterial species in a single assay

Inbiome aims to implement the "Molecular Culture" diagnostic test in hospitals to accurately identify bacterial infections within 4 hours, enhancing treatment and reducing costs.

€ 2.499.999

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

WEE-Detect

WEE-Detect onderzoekt het verbeteren van een slim luierplatform voor continue urine-monitoring van neonaten om overlevingskansen te vergroten.

€ 20.000
Mkb-innovati...

Innovatief patiënt monitoringsysteem voor sepsis in baby’s en jonge kinderen in lage- en middeninkomenslanden.

GOAL 3 ontwikkelt een betaalbaar patiëntmonitoringsysteem voor vroegtijdige detectie van septische shock bij baby’s in LMIL, gericht op het verbeteren van zorgcapaciteiten en -resultaten.

€ 20.000
ERC Proof of...

A tool to detect cognitive abnormalities in the first year of life based on electroencephalography (EEG)

The babylearn project aims to develop an EEG-based tool for early assessment of cognitive functions in infants, enhancing diagnosis and support for at-risk populations like premature babies.

€ 150.000
Mkb-innovati...

Premature baby's draadloos monitoren met de Bambi Belt

Het project ontwikkelt de Bambi Belt, een draadloos en huidvriendelijk monitoringsysteem voor premature baby’s, om stress en pijn te verminderen en de kwaliteit van zorg te verbeteren, wat ziekenhuisverblijven verkort en kosten verlaagt.

€ 348.460
Mkb-innovati...

Non-invasieve epilepsieaanval detectie

LivAssured en Momo Medical ontwikkelen een non-contact oplossing voor het detecteren van epilepsieaanvallen in bed, gericht op kwetsbare patiënten, om tijdige alarmmeldingen te faciliteren.

€ 156.030